Home Stock

Stock Research: Rohto Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Rohto Pharmaceutical

TYO:4527 JP3982400008
37
  • Value
    54
  • Growth
    31
  • Safety
    Safety
    63
  • Combined
    40
  • Sentiment
    49
  • 360° View
    360° View
    37
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

ROHTO PHARMACEUTICAL CO., LTD. is a Japan-based company engaged in health and beauty care. It primarily provides eye care products (eye drops, lotions), skin care products (dermatological preparations, lip balms, sunscreens, functional cosmetics), oral medication, and food-related products (digestive medicines, Chinese herbal medicines, supplements), as well as extracorporeal test drugs. The company operates in domestic and overseas markets, including Europe, Asia, and America. In the last fiscal year, the company had 9144 employees, a market cap of $3254 million, profits of $1167 million, and revenue of $2058 million.

more

ANALYSIS: With an Obermatt 360° View of 37 (better than 37% compared with alternatives), overall professional sentiment and financial characteristics for the stock Rohto Pharmaceutical are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Rohto Pharmaceutical. The consolidated Value Rank has an attractive rank of 54, which means that the share price of Rohto Pharmaceutical is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 54% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 63. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 49. Professional investors are more confident in 51% other stocks. The consolidated Growth Rank also has a low rank of 31, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 69 of its competitors have better growth. ...read more

more
Strongest Rank Market Pulse
Weakest Rank Pro Holdings
Country Japan
Industry Personal Products
Size Large
Website rohto.co.jp
Index
Rohto Pharmaceutical stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 3-Nov-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
54 59 40 51
Growth
31 24 35 33
Safety
Safety
63 75 82 77
Sentiment
49 56 16 49
360° View
360° View
37 65 36 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
59 30 51 33
Opinions Change
50 50 6 50
Pro Holdings
n/a 96 64 97
Market Pulse
1 41 42 38
Sentiment
49 56 16 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
54 59 40 51
Growth
31 24 35 33
Safety Safety
63 75 82 77
Combined
40 69 56 54
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
30 52 42 56
Price vs. Earnings (P/E)
55 62 51 49
Price vs. Book (P/B)
46 34 37 59
Dividend Yield
59 52 39 31
Value
54 59 40 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
68 69 31 32
Profit Growth
27 30 53 38
Capital Growth
15 22 35 63
Stock Returns
67 41 77 53
Growth
31 24 35 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
56 69 69 66
Refinancing
63 34 47 33
Liquidity
65 77 84 82
Safety Safety
63 75 82 77

Similar Stocks

Discover high‑ranked alternatives to Rohto Pharmaceutical and broaden your portfolio horizons.

Tokyo Century

TYO:8439
Country: Japan
Industry: Specialized Finance
Size: X-Large
Full Stock Analysis

Cosmo Energy Holdings

TYO:5021
Country: Japan
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

Omron

TYO:6645
Country: Japan
Industry: Electronic Components
Size: X-Large
Full Stock Analysis

Bridgestone

TYO:5108
Country: Japan
Industry: Tires & Rubber
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews